The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes
- PMID: 21251206
- DOI: 10.1111/j.1538-7836.2011.04204.x
The study of the effect of splicing mutations in von Willebrand factor using RNA isolated from patients' platelets and leukocytes
Abstract
Background: In von Willebrand factor (VWF) the effect of mutations potentially affecting mRNA processing or splicing is less predictable than that of other mutations (e.g. nonsense or missense substitutions). Bioinformatic tools can provide a valuable means to determine the consequences of potential splice site mutations (PSSM), but functional studies are mandatory to elucidate the true effect of the variation detected.
Objectives, patients and methods: After identification of PSSM in VWD patients, we began a systematic study of their in vivo effect in RNA extracted from the patients' platelets and leukocytes.
Results and conclusions: Thirteen pairs of primers were designed for full amplification of VWF mRNA by RT-PCR that, after sequencing of aberrant products, enabled elucidation of the PSSM consequences for mRNA processing. This procedure was used to study seven different PSSM identified in four patients demonstrating diverse molecular mechanisms such as exon skipping (c.533-2A>G and c.8155+3G>C) and the activation of a cryptic splice site (c.7730-1G>C). No visible effect was evident for c.1533+15G>A and c.5170+10C>T and the consequence of c.[546G>A;7082-2A>G] was hidden by nonsense-mediated mRNA decay (NMD). Results were compared with in silico predictions of four splice-site analysis tools. We demonstrate selective degradation of VWF mRNA bearing PSSM by NMD for several mutations, which suggests that NMD represents a general mechanism for truncating mutations in VWF. Furthermore, because NMD efficiency varies between cell types, use of RNA from both platelets and leukocytes for in vivo study of VWF PSSM offers complementary results, particularly in cases in which NMD occurs in the allele carrying the mutation.
© 2011 International Society on Thrombosis and Haemostasis.
Similar articles
-
Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA.Haematologica. 2019 Mar;104(3):587-598. doi: 10.3324/haematol.2018.203166. Epub 2018 Oct 25. Haematologica. 2019. PMID: 30361419 Free PMC article.
-
Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factor.Hum Mutat. 2022 Feb;43(2):215-227. doi: 10.1002/humu.24312. Epub 2021 Dec 17. Hum Mutat. 2022. PMID: 34882887
-
A synonymous (c.3390C>T) or a splice-site (c.3380-2A>G) mutation causes exon 26 skipping in four patients with von Willebrand disease (2A/IIE).J Thromb Haemost. 2013 Jul;11(7):1251-9. doi: 10.1111/jth.12280. J Thromb Haemost. 2013. PMID: 23621778
-
Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio.Acta Haematol. 2009;121(2-3):128-38. doi: 10.1159/000214853. Epub 2009 Jun 8. Acta Haematol. 2009. PMID: 19506359 Review.
-
Molecular genetics of type 2 von Willebrand disease.Int J Hematol. 2002 Jan;75(1):9-18. doi: 10.1007/BF02981973. Int J Hematol. 2002. PMID: 11843298 Review.
Cited by
-
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.Haematologica. 2017 Dec;102(12):2005-2014. doi: 10.3324/haematol.2017.168765. Epub 2017 Sep 29. Haematologica. 2017. PMID: 28971901 Free PMC article.
-
Characterization of aberrant splicing of von Willebrand factor in von Willebrand disease: an underrecognized mechanism.Blood. 2016 Jul 28;128(4):584-93. doi: 10.1182/blood-2015-10-678052. Epub 2016 Jun 17. Blood. 2016. PMID: 27317792 Free PMC article. Clinical Trial.
-
Next generation sequencing to dissect the genetic architecture of KNG1 and F11 loci using factor XI levels as an intermediate phenotype of thrombosis.PLoS One. 2017 Apr 26;12(4):e0176301. doi: 10.1371/journal.pone.0176301. eCollection 2017. PLoS One. 2017. PMID: 28445521 Free PMC article.
-
Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.Blood Adv. 2021 Aug 10;5(15):2987-3001. doi: 10.1182/bloodadvances.2020003397. Blood Adv. 2021. PMID: 34351388 Free PMC article.
-
Cryptic non-canonical splice site activation is part of the mechanism that abolishes multimer organization in the c.2269_2270del von Willebrand factor.Haematologica. 2020 Apr;105(4):1120-1128. doi: 10.3324/haematol.2019.222679. Epub 2019 Jul 18. Haematologica. 2020. PMID: 31320553 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous